ERVW-1 and infection: Infection with one or a few transmitter/founder (TF) virus(es) leads to the development of antibodies able to bind the viral envelope glycoprotein (Env) and neutralize the TF virus or other early viral viruses [2,4], thereby favoring the survival of escape variants.